| ID | Sequence | Length | GC content |
|---|---|---|---|
| GCUCAGCAUUUGGGGACGCUCUCAGCUCUCGGCGCACGGCCCAGGUUAU… | 1635 nt | 0.4740 | |
| GCUCAGCAUUUGGGGACGCUCUCAGCUCUCGGCGCACGGCCCAGGUAAG… | 1626 nt | 0.4859 | |
| GCUCAGCAUUUGGGGACGCUCUCAGCUCUCGGCGCACGGCCCAGGGUGA… | 1659 nt | 0.4653 | |
| GCUCAGCAUUUGGGGACGCUCUCAGCUCUCGGCGCACGGCCCAGCUUCC… | 1554 nt | 0.4736 |
This gene encodes a member of the annexin family. Members of this calcium-dependent phospholipid-binding protein family play a role in the regulation of cellular growth and in signal transduction pathways. This protein functions as an autocrine factor which heightens osteoclast formation and bone resorption. This gene has three pseudogenes located on chromosomes 4, 9 and 10, respectively. Multiple alternatively spliced transcript variants encoding different isoforms have been found for this gene. Annexin A2 expression has been found to correlate with resistance to treatment against various cancer forms. [provided by RefSeq, Dec 2019]
A study in mouse fetal cortical neurons identified a 156-nt cis-acting region within the NR1 mRNA 3'-UTR that specifically binds trans-acting proteins from polysomes, with this binding activity significantly upregulated by chronic ethanol exposure [Anji & Kumari DOI:10.1111/J.1460-9568.2006.04776.X].